1-8 of 8
Ian M. Thompson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Seth P. Lerner, David J. McConkey, Catherine M. Tangen, Joshua J. Meeks, Thomas W. Flaig, Xing Hua, Siamak Daneshmand, Ajjai Shivaram Alva, M. Scott Lucia, Dan Theodorescu, Amir Goldkorn, Matthew I. Milowsky, Woonyoung Choi, Rick Bangs, Daniel L. Gustafson, Melissa Plets, Ian M. Thompson, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 444–449.
https://doi.org/10.1158/1078-0432.CCR-23-0602
Published: 17 January 2024
View article titled, Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Open the PDF for Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)

Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand, Ajjai Alva, Seth P. Lerner, M. Scott Lucia, David J. McConkey, Dan Theodorescu, Amir Goldkorn, Matthew I. Milowsky, Rick Bangs, Gary R. MacVicar, Bruno R. Bastos, Jared S. Fowles, Daniel L. Gustafson, Melissa Plets, Ian M. Thompson, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (9): 2435–2441.
https://doi.org/10.1158/1078-0432.CCR-20-2409
Published: 01 May 2021
View article titled, A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Open the PDF for A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) in another window
Includes: Supplementary data
Journal Articles

Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer

Ya-Ting Hsu, Fei Gu, Yi-Wen Huang, Joseph Liu, Jianhua Ruan, Rui-Lan Huang, Chiou-Miin Wang, Chun-Liang Chen, Rohit R. Jadhav, Hung-Cheng Lai, David G. Mutch, Paul J. Goodfellow, Ian M. Thompson, Nameer B. Kirma, Tim Hui-Ming Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (22): 6272–6285.
https://doi.org/10.1158/1078-0432.CCR-13-1734
Published: 14 November 2013
View article titled, Promoter Hypomethylation of EpCAM-Regulated <em>Bone Morphogenetic Protein</em> Gene Family in Recurrent Endometrial Cancer
Open the PDF for Promoter Hypomethylation of EpCAM-Regulated <em>Bone Morphogenetic Protein</em> Gene Family in Recurrent Endometrial Cancer in another window
Includes: Supplementary data
Journal Articles

Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study

Daniel W. Lin, Lisa F. Newcomb, Elissa C. Brown, James D. Brooks, Peter R. Carroll, Ziding Feng, Martin E. Gleave, Raymond S. Lance, Martin G. Sanda, Ian M. Thompson, John T. Wei, Peter S. Nelson, for the Canary Prostate Active Surveillance Study Investigators
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2442–2450.
https://doi.org/10.1158/1078-0432.CCR-12-3283
Published: 30 April 2013
View article titled, Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
Open the PDF for Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study in another window
Includes: Supplementary data
Journal Articles

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

Tanya B. Dorff, Bryan Goldman, Jacek K. Pinski, Philip C. Mack, Primo N. Lara, Jr., Peter J. Van Veldhuizen, Jr., David I. Quinn, Nicholas J. Vogelzang, Ian M. Thompson, Jr., Maha H.A. Hussain
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (11): 3028–3034.
https://doi.org/10.1158/1078-0432.CCR-09-3122
Published: 31 May 2010
View article titled, Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Open the PDF for Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer in another window
Journal Articles

VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non–Hispanic White and Hispanic White Men

Kathleen C. Torkko, Adrie van Bokhoven, Phoung Mai, Joke Beuten, Ivana Balic, Tim E. Byers, John E. Hokanson, Jill M. Norris, Anna E. Barón, M. Scott Lucia, Ian M. Thompson, Robin J. Leach
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3223–3229.
https://doi.org/10.1158/1078-0432.CCR-07-4894
Published: 15 May 2008
View article titled, <em>VDR</em> and <em>SRD5A2</em> Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non–Hispanic White and Hispanic White Men
Open the PDF for <em>VDR</em> and <em>SRD5A2</em> Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non–Hispanic White and Hispanic White Men in another window
Journal Articles

Association of RNASEL Variants with Prostate Cancer Risk in Hispanic Caucasians and African Americans

Stacie J. Shook, Joke Beuten, Kathleen C. Torkko, Teresa L. Johnson-Pais, Dean A. Troyer, Ian M. Thompson, Robin J. Leach
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5959–5964.
https://doi.org/10.1158/1078-0432.CCR-07-0702
Published: 01 October 2007
View article titled, Association of RNASEL Variants with Prostate Cancer Risk in Hispanic Caucasians and African Americans
Open the PDF for Association of RNASEL Variants with Prostate Cancer Risk in Hispanic Caucasians and African Americans in another window
Journal Articles

Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of l-Selenomethionine: a Southwest Oncology Group Study

Anita L. Sabichi, J. Jack Lee, Robert J. Taylor, Ian M. Thompson, Brian J. Miles, Catherine M. Tangen, Lori M. Minasian, Louis L. Pisters, John R. Caton, Joseph W. Basler, Seth P. Lerner, David G. Menter, James R. Marshall, E. David Crawford, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2178–2184.
https://doi.org/10.1158/1078-0432.CCR-05-0937
Published: 11 April 2006
View article titled, Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of <em>l</em>-Selenomethionine: a Southwest Oncology Group Study
Open the PDF for Selenium Accumulation in Prostate Tissue During a Randomized, Controlled Short-term Trial of <em>l</em>-Selenomethionine: a Southwest Oncology Group Study in another window